Medison expands global leadership teamMedison expands global leadership team

Israel-based Medison, a creator of a first-of-its-kind unified global commercialization platform that accelerates the launch of breakthrough therapies, has announced two key additions to its global leadership team: Shay Tamari as chief business officer (CBO) and Tali Mirsky as chief legal and compliance officer (CLCO).

Medison says its platform enables biotech companies to plan, optimize, and launch their breakthrough therapies globally by utilizing Medison's end-to-end, seamless, affiliate-like model through a single, unified, centrally managed partnership.

As Medison continues to scale its operations and deepen partnerships with biotech companies around the world, strengthening its leadership capacity is essential to delivering sustainable value and impact. Mr Tamari and Ms Mirsky bring extensive global experience and strategic insight that will support the company's ability to execute across geographies, navigate increasing complexity, and uphold the highest standards of trust, ethics, and performance.